Previous studies have shown that age, the presence of liver cirrhosis, a later stage, a high Child-Pugh grade, a tumor of ≥5 cm, tumor multiplicity, the presence of satellites, a high AFP level, noncurative therapy, etc.5–9 result in a significant decrease in the survival of HCC patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.